The impact of locoregional treatment on survival of patients with primary metastatic breast cancer

The aim of the study was to investigate the impact of primary tumor locoregional treatment (surgery or/and radiotherapy) on overall survival in patients with primary metastatic breast cancer (PMBC). Materials and Methods: This retrospective study included 295 wo men aged from 23 to 76 years with PMB...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2017
Автори: Liubota, R., Cheshuk, V., Vereshchako, R., Zotov, O., Zaichuk, V., Anikusko, N., Liubota, I.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/137598
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:The impact of locoregional treatment on survival of patients with primary metastatic breast cancer / R. Liubota, V. Cheshuk, R. Vereshchako, O. Zotov, V. Zaichuk, N. Anikusko, I. Liubota // Experimental Oncology. — 2017 — Т. 39, № 1. — С. 75-77. — Бібліогр.: 13 назв. — англ.

Репозиторії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-137598
record_format dspace
spelling irk-123456789-1375982020-11-12T10:57:14Z The impact of locoregional treatment on survival of patients with primary metastatic breast cancer Liubota, R. Cheshuk, V. Vereshchako, R. Zotov, O. Zaichuk, V. Anikusko, N. Liubota, I. Short communications The aim of the study was to investigate the impact of primary tumor locoregional treatment (surgery or/and radiotherapy) on overall survival in patients with primary metastatic breast cancer (PMBC). Materials and Methods: This retrospective study included 295 wo men aged from 23 to 76 years with PMBC. Among the 295 patients, the effect of locoregional treatment of primary tumor on survival outcomes was evaluated in 177 women with distant metastases at diagnosis of breast cancer. 35 patient received breast surgery (group 1), 95 patients with PMBC — radiotherapy (group 2) and 47 patients — combination of breast surgery and radiation (group 3). The remaining 118 patients didn’t receive surgery or/and radiotherapy (group 4). All patients received systemic cytotoxic chemotherapy. Results: The groups of patients with PMBC did not differ significantly by age, menstrual function, ER status, Her2 receptor status, site of metastasis and number of metastatic lesions. 2- and 5-year overall survival in patients of group 1 was 54 and 32%, group 2 — 47 and 8%, group 3 — 73 and 18%, whereas in patients from group 4 — 26 and 9%, respectively. The median survival of patients who underwent surgery was 36 months, patients with PMBC who received radiotherapy — 24 months, patients who obtained combination of breast surgery and radiation — 30 months vs 18 months in patients who did not undergo primary tumor locoregional treatment. Conclusions: The results of this study showed a favourable effect of locoregional treatment in patients with PMBC. 2017 Article The impact of locoregional treatment on survival of patients with primary metastatic breast cancer / R. Liubota, V. Cheshuk, R. Vereshchako, O. Zotov, V. Zaichuk, N. Anikusko, I. Liubota // Experimental Oncology. — 2017 — Т. 39, № 1. — С. 75-77. — Бібліогр.: 13 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137598 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Short communications
Short communications
spellingShingle Short communications
Short communications
Liubota, R.
Cheshuk, V.
Vereshchako, R.
Zotov, O.
Zaichuk, V.
Anikusko, N.
Liubota, I.
The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
Experimental Oncology
description The aim of the study was to investigate the impact of primary tumor locoregional treatment (surgery or/and radiotherapy) on overall survival in patients with primary metastatic breast cancer (PMBC). Materials and Methods: This retrospective study included 295 wo men aged from 23 to 76 years with PMBC. Among the 295 patients, the effect of locoregional treatment of primary tumor on survival outcomes was evaluated in 177 women with distant metastases at diagnosis of breast cancer. 35 patient received breast surgery (group 1), 95 patients with PMBC — radiotherapy (group 2) and 47 patients — combination of breast surgery and radiation (group 3). The remaining 118 patients didn’t receive surgery or/and radiotherapy (group 4). All patients received systemic cytotoxic chemotherapy. Results: The groups of patients with PMBC did not differ significantly by age, menstrual function, ER status, Her2 receptor status, site of metastasis and number of metastatic lesions. 2- and 5-year overall survival in patients of group 1 was 54 and 32%, group 2 — 47 and 8%, group 3 — 73 and 18%, whereas in patients from group 4 — 26 and 9%, respectively. The median survival of patients who underwent surgery was 36 months, patients with PMBC who received radiotherapy — 24 months, patients who obtained combination of breast surgery and radiation — 30 months vs 18 months in patients who did not undergo primary tumor locoregional treatment. Conclusions: The results of this study showed a favourable effect of locoregional treatment in patients with PMBC.
format Article
author Liubota, R.
Cheshuk, V.
Vereshchako, R.
Zotov, O.
Zaichuk, V.
Anikusko, N.
Liubota, I.
author_facet Liubota, R.
Cheshuk, V.
Vereshchako, R.
Zotov, O.
Zaichuk, V.
Anikusko, N.
Liubota, I.
author_sort Liubota, R.
title The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
title_short The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
title_full The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
title_fullStr The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
title_full_unstemmed The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
title_sort impact of locoregional treatment on survival of patients with primary metastatic breast cancer
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2017
topic_facet Short communications
url http://dspace.nbuv.gov.ua/handle/123456789/137598
citation_txt The impact of locoregional treatment on survival of patients with primary metastatic breast cancer / R. Liubota, V. Cheshuk, R. Vereshchako, O. Zotov, V. Zaichuk, N. Anikusko, I. Liubota // Experimental Oncology. — 2017 — Т. 39, № 1. — С. 75-77. — Бібліогр.: 13 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT liubotar theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT cheshukv theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT vereshchakor theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT zotovo theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT zaichukv theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT anikuskon theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT liubotai theimpactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT liubotar impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT cheshukv impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT vereshchakor impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT zotovo impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT zaichukv impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT anikuskon impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
AT liubotai impactoflocoregionaltreatmentonsurvivalofpatientswithprimarymetastaticbreastcancer
first_indexed 2023-10-18T21:16:22Z
last_indexed 2023-10-18T21:16:22Z
_version_ 1796152372906426368